cetylpyridinium chloride anhydrous has been researched along with Abnormality, Heart in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breuer, CK; Church, S; Gilliland, T; Maxfield, MW; Naito, Y; Patterson, JT; Shinoka, T | 1 |
| Alton, GY; Divekar, A; Joffe, AR; Nettel-Aguirre, A; Rebeyka, IM; Robertson, CM; Ross, DB; Sauve, R; Selzer, S | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Abnormality, Heart
| Article | Year |
|---|---|
Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.
Topics: Animals; Blood Vessel Prosthesis; Clinical Trials as Topic; Health; Heart Defects, Congenital; Humans; Neovascularization, Physiologic; Translational Research, Biomedical | 2012 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Abnormality, Heart
| Article | Year |
|---|---|
Early childhood health, growth, and neurodevelopmental outcomes after complete repair of total anomalous pulmonary venous connection at 6 weeks or younger.
Topics: Age Factors; Cardiac Surgical Procedures; Child Development; Female; Health; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Nervous System; Neuropsychological Tests; Pulmonary Veins | 2007 |